ThyroShield, a liquid form of potassium iodide, has been approved by the FDA, for use as a protective agent in the event of a nuclear accident or release. The product is made by Fleming Pharmaceuticals. Potassium iodide binds to the thyroid, preventing it from absorbing radioactive iodine in nuclear releases, and can protect the thyroid from damage that may result in development of cancer or other thyroid conditions later in life. The thyroid glands of children, infants and babies in utero are at the greatest risk from radioactive iodine, and the liquid is designed to be easier to give to children, particularly when giving potassium iodide is time-sensitive in the event of a nuclear emergency. The black raspberry-flavored liquid, which comes with a dropper, will eventually be sold through pharmacies and the Internet at an estimated price of less than $20 per one-ounce bottle. See the FDA notice
Comments
No comments yet. Leave a Comment

